Filamin A regulates MMP-9 expression and suppresses prostate cancer cell migration and invasion

Tumor Biology

Volumn 35, Issue 4, 2014, Pages 3819-3826

  Sun, G G ^a   Lu, Y F ^b   Zhang, J ^c   Hu, W N ^a  

^a TANGSHAN PEOPLE S HOSPITAL   (China)

^b Tangshan Workers Hospital   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

FLNA; Immunohistochemical analysis; MMP 9; Prostate carcinoma

Indexed keywords

FILAMIN A; GELATINASE B; PROSTATE ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER STAGING; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; TUMOR INVASION;

AGED; CELL MOVEMENT; FILAMINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATIC NEOPLASMS;

EID: 84899055323     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1504-6     Document Type: Article

References (22)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin. 2000;50:7-33.
2. Dong JT, Isaacs WB, Isaacs JT. Molecular advances in prostate cancer. Curr Opin Oncol. 1997;9:101-7.
3. Zhou X, Boren J, Akyurek LM. Filamins in cardiovascular development. Trends Cardiovasc Med. 2007;17:222-9.
4. Ai J, Huang H, Lv X, Tang Z, Chen M, Chen T, et al. FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma. Cell Physiol Biochem. 2011;27:207-16.
5. Stossel TP, Condeelis J, Cooley L, Hartwig JH, Noegel A, Schleicher M, et al. Filamins as integrators of cell mechanics and signalling. Nat Rev Mol Cell Biol. 2001;2:138-45.
6. Sheen VL, Feng Y, Graham D, Takafuta T, Shapiro SS, Walsh CA. Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact. Hum Mol Genet. 2002;11:2845-54.
7. Feng Y, Walsh CA. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol. 2004;6:1034-8.
8. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM, et al. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res. 2009;15:788-96.
9. Bourguignon LY, Gilad E, Peyrollier K. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem. 2007;282:19426-41.
10. Feng YY, Walsh CA. The many faces of flamin: a versatile molecular scaffold for cell motility and signaling. Nat Cell Biol. 2004;6:1034-8.
11. Nakamura F, Osborn TM, Hartemink CA, Hartwig JH, Stossel TP. Structure basis of filamin A functions. J Cell Biol. 2007;179:1011-25.
12. Roberson SP, Twigg SR, Sutherland-Smith AJ, Biancalana V, Gorlin RJ, Horn D, et al. Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans. Nat Genet. 2003;33:487-91.
13. Keshamouni VG, Michailidis G, Grasso CS, Anthwal S, Strahler JR, Walker A, et al. Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res. 2006;5:1143-54.
14. Shi JW, Yu YM, Wang SJ, Zhang J, Wang GY. Expressions of filamin A and matrix metalloproteinase 9 in colorectal adenocarcinoma and their significance. Tumor. 2010;30:768-73.
15. Wu YP, Li JB, Zhao RJ, Zhao RJ, Wang XL, Shan BE, et al. Expression of filamin A in invasive breast carcinoma and its significance. Tumor. 2009;29:659-62.
16. Watanabe H. Extracellular matrix-regulation of cancer invasion and metastasis. Gan ToKagaku Ryoho. 2010;37:2058-61.
17. Yu HB, Zhang HF, Li DY, Zhang X, Xue HZ, Zhao SH. Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. J Asian Nat Prod Res. 2011;13:242-50.
18. Zhang M, Zhu GY, Gao HY, Zhao SP, Xue Y. Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in nasopharyngeal adenocarcinoma. J Surg Oncol. 2011;103:243-7.
19. Yang S, Du J, Wang Z, Yuan W, Qiao Y, Zhang M, et al. BMP-6 promotes E-cadherin expression through repressing delta EF1 in breast cancer cells. BMC Cancer. 2007;7:211.
20. Onoprishvili I, Ali S, Andria ML, Shpigel A, Simon EJ. Filamin A mutant lacking actin-binding domain restores mu opioid receptor regulation in melanoma cells. Neurochem Res. 2008;33:2054-61.
21. Zhu TN, He HJ, Kole S, D'Souza T, Agarwal R, Morin PJ, et al. Filamin A-mediated down-regulation of the exchange factor Ras-GRF1 correlates with decreased matrix metalloproteinase-9 expression in human melanoma cells. J Biol Chem. 2007;282:14816-26.
22. He HJ, Kole S, Kwon YK, Crow MT, Bernier M. Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway. J Biol Chem. 2003;278:27096-104.